PT Merck Tbk (ISX:MERK) Beta: 0.2881 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:MERK PT Merck Tbk ISX:MERK
84 GF Score
Price Rp3,760.00
GF Value Rp4,944.61
Valuation Modestly Undervalued
View Full Analysis

What is PT Merck Tbk Beta?

PT Merck Tbk ISX:MERK +0.53% 84 Beta is 0.2881 as of Jul. 14, 2026. GuruFocus rates ISX:MERK with a GF Score™ of 84/100 and a GF Value™ of Rp4,944.61 (Modestly Undervalued).

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-14), PT Merck Tbk's Beta is 0.2881.


PT Merck Tbk  (ISX:MERK) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


PT Merck Tbk Beta Related Terms


PT Merck Tbk Beta Historical Data

* Premium members only.

The historical data trend for PT Merck Tbk's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Merck Tbk Beta Chart

PT Merck Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.30 1.32 0.78 -0.01 0.35

PT Merck Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.63 0.29 0.35 0.31

ISX:MERK vs ZTS, UTHR, VTRS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PT Merck Tbk's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Merck Tbk Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Merck Tbk's Beta distribution charts can be found below:

* The bar in red indicates where PT Merck Tbk's Beta falls into.


ISX:MERK
84GF Score
PT Merck Tbk ISX:MERK
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Merck Tbk Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.2881 mean?
PT Merck Tbk (ISX:MERK) has a Beta of 0.2881 as of Jul. 14, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for PT Merck Tbk and its competitors.
Is PT Merck Tbk's Beta too high?
PT Merck Tbk's current Beta is 0.2881. Overall, PT Merck Tbk has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Merck Tbk's Beta compare to ZTS and UTHR?
PT Merck Tbk's Beta of 0.2881 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for PT Merck Tbk and its competitors. PT Merck Tbk's current Beta is 0.2881. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Merck Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Merck Tbk (ISX:MERK) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp4,944.61, compared to a current price of Rp3,760.00 — trading 24% below its estimated fair value. The current Beta is 0.2881. PT Merck Tbk's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For PT Merck Tbk (ISX:MERK), the current Beta is 0.2881 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Merck Tbk (ISX:MERK) Overvalued in 2026?

Based on GuruFocus' analysis, PT Merck Tbk stock appears to be undervalued. The current stock price of Rp3,760.00 is trading 24% below its estimated GF Value™ of Rp4,944.61. GuruFocus considers PT Merck Tbk to be Modestly Undervalued.

Key valuation signals for ISX:MERK:

  • Beta: 0.2881
  • GF Value™: Rp4,944.61 vs. price of Rp3,760.00 (24% below fair value)
  • GF Score™: 84/100

No single metric tells the full story. See the ISX:MERK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Merck Tbk Business Description

Address Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines for colorectal cancer, head and neck tumors, multiple sclerosis, infertility, growth hormone disorders, cardiovascular disorders, diabetes, as well as thyroid disorders such as hypothyroidism.
84GF Score

Get the complete analysis for ISX:MERK

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp3,760.00
Price
Rp4,944.61
GF Value